Fluticasone propionate in children with moderate asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 4 I, 1996, Pages 1039-1044

  Hoekstra, M O ^a   Grol, Marion H ^b   Bouman, Katelijne ^b   Stijnen, T ^b   Koeter G H ^b   Kauffman, H F ^b   Gerritsen, J ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; FLUTICASONE; HYDROCORTISONE; SALBUTAMOL;

ADOLESCENT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHALATIONAL DRUG ADMINISTRATION; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STEROID THERAPY;

EID: 0029969062     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.4.8887604     Document Type: Article

References (26)

1. Anderson, H. R. 1992. Epidemiology of asthma. Br. J. Hosp. Med. 47:99-104.
2. Warner, J. O., M. Gotz, L. I. Landau, et al. 1989. Management of asthma: a concensus statement. Arch. Dis. Child. 64:1065-1079.
3. van Essen-Zandvliet, E. E. M., M. D. Hughes, H. J. Waalkens, E. J. Duiverman, S. J. Pocock, K. F. Kerrebijn, and the Dutch CNSLD study group. 1992. Effects of 22 months treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness and symptoms in children with asthma. Am. Rev. Respir. Dis. 146:547-554.
4. Geddes, D. M. 1992. Inhaled corticosteroids: benefits and risks. Thorax 47:404-407.
5. König, P. 1993. The risks and benefits of inhaled corticosteroids. Eur. Respir. Rev. 15:501-505.
6. Priftis, K., A. D. Milner, E. Conway, and J. W. Honour, 1990. Adrenal function in asthma. Arch. Dis. Child. 65:830-840.
7. Harding, S. M. 1990. The human pharmacology of fluticasone propionate. Respir. Med. 84(Suppl. A):25-29.
8. Gustafsson, P., J. Tsanakas, M. Gold, R. Primhak, M. Radford, and E. Gillies. 1993. Comparison of the efficacy and safety of inhaled fluticasone propionate 200 μg/day with inhaled beclomethasone dipropionate 400 μg/day in mild and moderate asthma. Arch. Dis. Child. 69:206-211.
9. Burrows, B., N. Huang, R. Hughes, R. Johnston, K. Kilburn, Ch. Kuhn, W. Miller, M. Mitchell, G. Snider, from the ACCP-ATS joint committee on pulmonary nomenclature. 1975. Pulmonary terms and symbols. Chest 67:583-593.
10. Roorda, R. J., J. Gerritsen, W. M. C. v. Aalderen, J. P. Schouten, and K. Knol. 1991. Repeated provocation tests in asthmatic children for testing tachyphylaxis to histamine. Pediatr. Pulmonol. 10:106-111.
11. Waalkens, H. J., P. J. F. M. Merkus, E. E. M. van Essen-Zandvliet, P. L. P. Brand, J. Gerritsen, E. J. Duiverman, K. F. Kerrebijn, K. Knol, Ph. H. Quanjer, and the Dutch CNSLD study group. 1993. Assessment of bronchodilator response in children with asthma. Eur. Respir. J. 6:645-651.
12. Mackenzie, C. A., E. G. Weinberg, E. Tabachnik, M. Taylor, J. Havnen, and K. Crescenzi. 1993. A Placebo controlled trial of fluticasone propionate in children. Eur. J. Pediatr. 152:856-860.
13. Zapletal, A. 1987. Lung function in children and adolescents. Methods, reference values. In A. Zapletal, M. Samanek, T. Paul, et al., editors. Progress in respiratory research. Karger, Basel. 114-128.
14. Waalkens, H. J., J. Gerritsen, G. H. Koëter, F. H. Krouwels, W. M. C. van Aalderen, and K. Knol. 1991. Budesonide and terbutaline or terbutaline alone in children with mild asthma: effects on airway hyperresponsiveness and diurnal variation in peak flow. Thorax 46:499-503.
15. Price, J. F., and P. H. Weller. 1995. Comparison of fluticasone propionate and sodium cromoglycate in asthma. Respir. Med. 89:363-368.
16. Chung, K. F. 1986. Role of inflammation in the hyperreactivity of the airways in asthma. Thorax 41:657-662.
17. Kraan, J., G. H. Koëter, Th. W. van de Mark, M. Boorsma, J. Kukler, H. J. Sluiter, and K. de Vries. 1988. Dosage and time effects of inhaled budesonide on bronchial hyperresponsiveness. Am. Rev. Respir. Dis. 137:44-48.
18. Waalkens, H. J., E. E. M. van Essen-Zandvliet, M. D. Hughes, J. Gerritsen, E. J. Duiverman, K. Knol, and K. F. Kerrebijn. 1993. Cessation of long-term treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. Am. Rev. Respir. Dis. 148:1252-1257.
19. Lundback, B., R. Dahl, M. De Jonghe, N. Hyldebrandt, R. Valta, and S. L. Payne. 1994. A comparison of fluticasone propionate when delivered by either the metered-dose inhaler or the Diskhaler inhaler in the treatment of mild-to-moderate asthma. Eur. J. Clin. Res. 5:11-19.
20. -1) administered by pressurized inhaler. Respir. Med. 87:609-620.
21. Kerrebijn, K. F. 1976. Beclomethasone dipropionate in long-term treatment of asthma in children. J. Pediatr. 89:821-826.
22. Nassif, E., M. Weinberger, B. Sherman, and K. Brown. 1987. Extrapulmonary effect of maintenance corticosteroid therapy with alternate day prednisone and inhaled beclomethasone in children with chronic asthma. J. Allergy Clin. Immunol. 80:518-529.
23. Volovitz, B, J. Amir, H. Malik, A. Kauschansky, and I. Varsano. 1993. Growth and pituitary-adrenal function in children with severe asthma treated with inhaled budesonide. N. Engl. J. Med. 329:1703-1708.
24. Francis, R. S. 1976. Long-term beclomethasone dipropionate aerosol therapy in juvenile asthma. Thorax 31:309-314.
25. Utiger, R. D. 1993. Differences between inhaled and oral glucocorticoid therapy. N. Engl. J. Med. 329:1731-1733.
26. Padfield, P. L., and S. Teelucksingh. 1993. Inhaled corticosteroids: the endocrinologist's view. Eur. Respir. Rev. 3:494-500.